Vigilant Biosciences Announces Oral Presentation on CD44 and Associated Markers in Oral Rinses and Tissues from Oral Cancer Patients at AHNS 9th International Conference on Head and Neck Cancer 7.14.16

July 13, 2016 FORT LAUDERDALE, Fla. and SEATTLE, AHNS Conference – July 13, 2016 – Vigilant Biosciences, Inc., a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, today announced a presentation of data related to proof-of-concept studies by...

R&D Tax Credit Now Yields Refunds for Start-up Companies 6.28.16

TRCG Advisors helps companies identify tax credits to potentially reduce liability and produce refunds The Federal R&D tax credit is a dollar-for-dollar reduction of federal income tax liability for qualified expenditures incident to the development or improvement of a product, process,...

Florida Patent Pro Bono Reaches One Year Milestone 6.27.16

GAINESVILLE and BOCA RATON, Fla., May 11, 2016 /PRNewswire-USNewswire/ -- The Florida Institute for the Commercialization of Public Research (the Institute) announced the one year anniversary of the Florida Patent Pro Bono (FloBono) Program. Launched in May of 2015 with the assistance of the U.S....

NASA Awards Grant to Local Startup to Turn Space-Tech to Bio-Tech 6.27.16

POSTED ON  JUNE 6, 2016 BY C&S ORLANDO, Fla., June 6, 2016 /PRNewswire/ — Aviana Molecular Technologies, (Aviana) a development-stage diagnostic startup company, received an STTR grant from NASA to develop sensors to be used on vehicles in extra-terrestrial missions and repurpose them as...

Florida Institute Funds Admiral to Avert Adblock Armageddon 6.23.16

Institute Joins Admiral Investor Syndicate Including Five Venture Funds from Across the US GAINESVILLE and BOCA RATON, Fla., June 20, 2016 -- The Florida Institute for the Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with Admiral,...


Facebook icon
Twitter icon
LinkedIn icon
Pinterest icon
e-mail icon